AGL 38.50 Increased By ▲ 0.93 (2.48%)
AIRLINK 131.80 Decreased By ▼ -0.70 (-0.53%)
BOP 5.60 Decreased By ▼ -0.04 (-0.71%)
CNERGY 3.84 Increased By ▲ 0.07 (1.86%)
DCL 8.70 Decreased By ▼ -0.17 (-1.92%)
DFML 40.80 Decreased By ▼ -0.20 (-0.49%)
DGKC 89.00 Decreased By ▼ -1.16 (-1.29%)
FCCL 35.22 Increased By ▲ 0.14 (0.4%)
FFBL 66.45 Decreased By ▼ -0.05 (-0.08%)
FFL 10.43 Increased By ▲ 0.28 (2.76%)
HUBC 109.61 Increased By ▲ 3.21 (3.02%)
HUMNL 14.66 Increased By ▲ 1.26 (9.4%)
KEL 4.83 Decreased By ▼ -0.03 (-0.62%)
KOSM 7.07 Increased By ▲ 0.22 (3.21%)
MLCF 42.60 Increased By ▲ 0.80 (1.91%)
NBP 59.00 Increased By ▲ 0.42 (0.72%)
OGDC 184.28 Increased By ▲ 3.03 (1.67%)
PAEL 25.70 No Change ▼ 0.00 (0%)
PIBTL 5.90 Increased By ▲ 0.07 (1.2%)
PPL 147.80 Decreased By ▼ -0.60 (-0.4%)
PRL 23.61 Increased By ▲ 0.39 (1.68%)
PTC 16.45 Increased By ▲ 1.21 (7.94%)
SEARL 69.20 Increased By ▲ 0.41 (0.6%)
TELE 7.23 Decreased By ▼ -0.01 (-0.14%)
TOMCL 36.11 Increased By ▲ 0.11 (0.31%)
TPLP 7.56 Increased By ▲ 0.16 (2.16%)
TREET 14.19 Decreased By ▼ -0.05 (-0.35%)
TRG 50.86 Increased By ▲ 0.01 (0.02%)
UNITY 26.89 Increased By ▲ 0.49 (1.86%)
WTL 1.23 Increased By ▲ 0.02 (1.65%)
BR100 9,822 Increased By 54.5 (0.56%)
BR30 29,806 Increased By 405.7 (1.38%)
KSE100 92,378 Increased By 440 (0.48%)
KSE30 28,835 Increased By 91.6 (0.32%)

PARIS: French prosecutors have indicted pharma giant Sanofi for manslaughter over birth defects linked to an epilepsy drug, the company said Monday, in a long-running case that has also seen it charged with fraud.

The charges relate to the drug valproate, marketed as Depakine among other trade names, which studies say has caused disabilities in about 15,000-30,000 children whose mothers took the medicine while pregnant.

On the market since 1967, the drug is used to treat epilepsy, migraines and bipolar disorder.

But research found that when pregnant women took the drug, their children had an elevated risk - between 10 to 40 percent - of congenital malformations, autism and learning difficulties.

Sanofi is facing separate charges of aggravated fraud and unintentionally causing injury in 42 cases filed by families, but insists it had warned health authorities of the drug's risks already in the 1980s.

On Monday, the company confirmed a report in Le Monde newspaper that prosecutors have now also charged it with manslaughter.

But in a statement sent to AFP it insisted it had "fulfilled its obligation" of providing information on the drug and its side-effects, and said it "contests the validity of these proceedings."

Comments

Comments are closed.